First-Day-of-Life Rectal Swabs Fail To Represent Meconial Microbiota Composition and Underestimate the Presence of

S Graspeuntner1,2, M Lupatsii1, L Dashdorj3

  • 1Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.

Microbiology Spectrum
|April 25, 2023
PubMed

Insights

Rectal swabs are not a reliable proxy for infant gut microbiome analysis in the first days of life. Meconium samples provide distinct microbial patterns compared to swabs, highlighting the need for accurate neonatal microbiome research methods.

Area of Science:

  • Microbiology
  • Neonatal Health
  • Gut Microbiome Research

Background:

  • The gut microbiome is crucial for health, with early life being a key developmental window.
  • Stool samples are standard for gut microbiome studies, but alternative methods are sought due to acquisition challenges.
  • Rectal swabs are used in adults but their suitability for newborns is questioned.

Purpose of the Study:

  • To compare the reliability of rectal swabs versus meconium samples for infant gut microbiome analysis.
  • To assess differences in microbial composition, diversity, and resistance genes between the two sampling methods.
  • To determine if rectal swabs are a valid proxy for meconium in early neonatal microbiome research.

Main Methods:

  • Paired rectal swab and meconium samples were collected from newborns.
  • Microbial composition, alpha and beta diversity were analyzed.
  • Detection of resistance genes was compared between the two sample types.

Main Results:

  • Rectal swabs and meconium samples showed significantly distinct microbial compositions.
  • Alpha and beta diversity patterns differed notably between the sampling methods.
  • Dissimilarity between swab and meconium data exceeded interindividual variation.
  • Resistance gene detection varied significantly between the two approaches.

Conclusions:

  • Rectal swabs are not a reliable proxy for meconium-based gut microbiome analysis in newborns.
  • Using rectal swabs may lead to erroneous data interpretation in neonatal microbiome studies.
  • Accurate sampling methods are critical for understanding neonatal health and gut microbiota development.

Related Concept Videos

Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...